Navigation Links
All Intravascular Devices Pose Risk of Bloodstream Infection to Patients

All types of intravascular devices (IVDs) pose a risk of bloodstream infection to exposed hospitalized adult patients//, finds a study published in the September issue of Mayo Clinic Proceedings. What’s more, IVDs have become the leading cause of bloodstream infections in health care settings in the United States and worldwide. An IVD is described as any device that allows access to the bloodstream, but typically a catheter.

As many as 500,000 IVD-related bloodstream infections occur in the United States each year and lead to increased morbidity and prolonged hospital stays, from 10 to 20 days, costing $4,000 to $56,000 per episode. Catheter- or device-related bloodstream infections are widely considered the most preventable class of infections occurring in hospitals.

Authors of the IVD article in Mayo’s medical journal extracted data from 200 prospective studies to examine the risk of IVD-related bloodstream infections associated with each type of IVD. Lead author Dennis Maki, M.D., a researcher and infectious disease and critical care specialist at the University of Wisconsin Hospital and Clinics in Madison, says the findings offer “hard data” that IVDs pose a risk to all recipients.

“We thought this analysis might provide a unique opportunity to wave the flag and convince both health care workers and patients that all types of IVDs pose a risk,” Dr. Maki says. “Clinicians and quality assurance experts need to understand that these risks are significant and are often greater than they might think.”

The use of specialized IVDs for long-term or indefinite vascular access has dramatically increased in recent years in hospital and especially outpatient settings, but attention to reducing incidence of bloodstream infections has focused almost exclusively on patients with short-term central venous catheters in intensive care units, Dr. Maki says. In the last decade, virtually all progress in control of IVD-related bloodstr eam infections has been restricted to this relatively small fraction of hospitalized patients.

The same strategies need to be implemented on a far wider scale, argue the researchers, to make IVDs safer for all hospitalized patients, as well as outpatients who have IVDs.

Guidelines -- such as those published by the Centers for Disease Control’s (CDC) Hospital Infection Control Practices Advisory Committee in 2002 -- exist for prevention of IVD-related bloodstream infections and need to be adapted more widely by health care providers to ensure safer IVD use. Reduced bloodstream infections will follow, predicts Dr. Maki.

The article’s authors also urge wider use of novel IVD technologies designed to reduce IVD-related bloodstream infections. In an accompanying editorial, David Snydman, M.D., of Tufts-New England Medical Center, also cites advancing technology as a promising means for reducing IVD-related bloodstream infections.

“Technology holds far more promise for reducing risk than behavioral modification,” Dr. Maki says. “We believe that it holds the greatest promise. In our paper, we point up a number of IVD technologies that have been proven to be effective, but, as yet, inexplicably, aren’t widely used.”

Although consumers may be surprised to learn that all IVDs carry a risk of bloodstream infection, Dr. Maki advises them to become better informed, not alarmed. Vascular access is absolutely essential to today’s health care and in many cases is lifesaving, he says. But if an IVD insertion is scheduled, patients should feel comfortable asking their health care providers what measures will be taken to minimize their risk of bloodstream infection, Dr. Maki says.



Source-ewswise
SRM
'"/>




Related medicine news :

1. Injection supports Heart Devices
2. Government Organisation Proposes Strict Guidelines For SubStandard Medical Devices
3. Making MRIs Safe for Patients With Implantable Heart Devices
4. Scientists Concerned Over Increasing Malfunction Of Heart Devices
5. Anti-Microbial Coating For Use Over Biomedical Devices Developed
6. Scrutiny Sought For Reused Devices in U.S.
7. Sleep Apnea Can Be Treated With Oral Devices
8. Sensing Devices to Measure Sleep In the Pipeline
9. Current Cooling Devices Ineffective in Preventing Brain Injury
10. Computer Assisted Neuro-Rehabilitation Devices Way of the Future
11. Epilepsy Treated with Implanted Devices
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:3/29/2017)... ... March 29, 2017 , ... An ... braces. "The rubber bands used in conjunction with my braces always rubbed against ... design a way to prevent this problem." The O.B.S. was the result of ...
(Date:3/29/2017)... Yorba Linda, Ca (PRWEB) , ... March 29, 2017 , ... ... treatment of a growing number of cancers and is touted to be the next ... of treatment, thus far, has been in the form of immune checkpoint inhibitors such ...
(Date:3/29/2017)... ... March 29, 2017 , ... ... (SOGO™), a specialized continuing medical education conference for clinicians who manage some of ... Square, New York. , The program will be led by co- chairs ...
(Date:3/29/2017)... ... March 29, 2017 , ... VisualSP has helped over 1.5 ... the only option for on-premises installation of its Help System for SharePoint was at ... the system into the entire tenant. , The company recently released a modified ...
(Date:3/28/2017)... ... ... getting birth control isn’t as easy as it should be. In fact, millions of women ... care facility or a pharmacy within 60 minutes of where they live. This is especially ... are faced with health or personal issues that leave them homebound. To help facilitate better ...
Breaking Medicine News(10 mins):
(Date:3/28/2017)... , March 28, 2017  Medeon Biodesign, Inc., ... company, is pleased to announce that the Company ... of Panther Orthopedics, Inc., a San ... fixation solutions for orthopedic extremity applications.  ... expand rapidly, primarily due to procedure volume growth, ...
(Date:3/28/2017)...  Rosen Law Firm, a global investor rights law ... on behalf of purchasers of Kitov Pharmaceutical Holdings Ltd. ... to Kitov,s initial public offering on or about November ... from November 20, 2015 through February 3, 2017, both ... recover damages for Kitov investors under the federal securities ...
(Date:3/28/2017)... Summary GBI ... a Key Component of Multichannel Marketing" provides a ... in the digital age. While the pharmaceutical ... advancements, it has been much slower to adopt ... traditional channels and methods. However, the decreasing effectiveness ...
Breaking Medicine Technology: